Anand Padmanabhan

Anand Padmanabhan

Company: Retham Technologies

Job title: President and Chief Science Officer


1:45 pm Off-the-shelf RethamTM Platelets for Assessment of Platelet Activation by Therapeutic IgG mAb Drug Candidates 1:45 pm

Platelet activation induced by IgG monoclonal antibodies can significantly increase risk for adverse thrombotic events. Evaluation of the potential for induction of platelet activation by therapeutic IgG mabs can be challenging, requiring fresh healthy-donor platelets, and sensitive activation readouts. Long-term stored RethamTM platelets that have intact FcGRIIa signaling, developed using recent breakthrough technology, can be…Read more

day: Conference Day One

A Hanson Wade Group Company

© Copyright 2024 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.